Efficacy and safety of Xingbei Zhike granules in treatment of postinfectious cough (Wind-heat Invading the Lung Syndrome): A multicenter, randomized, double-blind, placebo-controlled trial

Guangdong Province Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients meet the diagnosis standard of post-infectious cough;
•(2) The TCM classification is Wind-heat Invading the Lung Syndrome;
•(3) Scores of cough >=3 (during day and night);
•(4) Aged 18 to 65 years old (including 18 and 65 years old);
•(5) Patients have been fully informed and voluntarily signed the informed consent.

•(1) Patients with gastroesophageal reflux disease, cough variant asthma, eosinophilia bronchitis, bronchiectasis, bronchial asthma or chronic obstructive pulmonary disease;
•(2) White blood cell count >12*10^9/L, and neutrophil greater than ULN;
•(3) Patients with cardio-cerebrovascular, liver, kidney, or hematological disease, or other serious primary diseases. ALT or AST> 1.5 ULN, serum creatinine > 1.5 ULN;
•(4) Suspected or proven history of alcohol or drug abuse, or a person with a mental illness;
•(5) Pregnant or lactating women, or women who have birth plan;
•(6) Allergic constitution or be allergy to the drug composition used in the trial;
•(7) patients who is participating or participated in last 3 months in other drug clinical trial.

发起方

Guangdong Province Hospital of Traditional Chinese Medicine